CLINICAL RESEARCH OF COVID-19

CLINICAL RESEARCH OF COVID-19

There is a network that is an COVID-19 academic research communication platform built by Ministry of Science and Technology of the People’s Republic of China, National Health Commission of the People’s Republic of China, China Association for Science and Technology, and Chinese Medical Association. Besides, there are some articles about research on SARS-CoV-2 antibody and Research on Laboratory Testing for COVID-19.

COVID-19 Academic Research Communication Platform
《Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019》 Zhao J, Yuan Q, Wang H, et al. Clin Infect Dis. 2020 Mar 28.
《Viral Kinetics and Antibody Responses in Patients with COVID-19》 Tan W, Lu Y, Zhang J, et al. medRxiv, 2020.
《Evaluation of Nucleocapsid and Spike Protein-based ELISAs for detecting antibodies against SARS-CoV-2》 Liu W, Liu L, Kou G, et al. Journal of Clinical Microbiology, 2020.
《Elevated serum IgM levels indicate poor outcome in patients with coronavirus disease 2019 pneumonia: A retrospective case-control study》 Wang Z, Li H, Li J, et al. medRxiv, 2020.
《Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.》 Tang N, Li D, Wang X, et al. J Thromb Haemost. 2020 Apr;18(4):844-847.
《Prominent changes in blood coagulation of patients with SARS-CoV-2 infection》 Han H, Yang L, Liu R, et al. Clin Chem Lab Med. 2020 Mar 16.
Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)  Suxin Wan, Qingjie Yi, Shibing Fan, Jinglong Lv, Xianxiang Zhang, Lian Guo,Chunhui Lang, Qing Xiao,Kaihu Xiao, Zhengjun Yi, Mao Qiang, Jianglin Xiang,Bangshuo Zhang, Yongping Chen